{"id":"NCT01687296","sponsor":"GlaxoSmithKline","briefTitle":"Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma","officialTitle":"A Multicentre, Randomized, Double-blind, Double-dummy, Active-controlled, Parallel-group Study to Determine the Efficacy and Safety of Nebulized Fluticasone Propionate 1mg Twice Daily Compared With Oral Prednisone Administered for 7 Days to Chinese Pediatric and Adolescent Subjects (Aged 4 to 16 Years) With an Acute Exacerbation of Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11-12","primaryCompletion":"2013-06-01","completion":"2013-06-21","firstPosted":"2012-09-18","resultsPosted":"2018-01-30","lastUpdate":"2018-06-20"},"enrollment":261,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"fluticasone propionate inhalation solution","otherNames":[]},{"type":"DRUG","name":"oral prednisone","otherNames":[]},{"type":"DRUG","name":"placebo inhalation solution","otherNames":[]},{"type":"DRUG","name":"placebo tablet","otherNames":[]},{"type":"DRUG","name":"salbutamol","otherNames":[]}],"arms":[{"label":"fluticasone Nebules/placebo tablet","type":"EXPERIMENTAL"},{"label":"oral prednisone/placebo inhalation solution","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study to determine the efficacy and safety of nebulized fluticasone propionate 1mg twice daily compared with oral prednisone administered for 7 days to Chinese pediatric and adolescent subjects (aged 4 to 16 years) with an acute exacerbation of asthma","primaryOutcome":{"measure":"Mean Morning Peak Expiratory Flow (AM PEF) on Diary Card Over the Treatment Assessment Period in Intent-to-Treat (ITT) Population","timeFrame":"Days 2 to 8","effectByArm":[{"arm":"Fluticasone Propionate","deltaMin":188.77,"sd":3.774},{"arm":"Prednisone","deltaMin":188.31,"sd":3.79}],"pValues":[{"comp":"OG000 vs OG001","p":"0.931"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":11,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":123},"commonTop":["White blood cell count increased"]}}